Conformation‐Dependent Anti‐Amyloid Oligomer Antibodies
- 1 January 2006
- book chapter
- Published by Elsevier in Methods in Enzymology
- Vol. 413, 326-344
- https://doi.org/10.1016/s0076-6879(06)13017-7
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- In vitro Conversion of Full-length Mammalian Prion Protein Produces Amyloid Form with Physical Properties of PrPScJournal of Molecular Biology, 2005
- Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer AdditionPLoS Biology, 2004
- Pauling and Corey's α-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid diseaseProceedings of the National Academy of Sciences, 2004
- Rationalization of the effects of mutations on peptide andprotein aggregation ratesNature, 2003
- Protofibrillar Islet Amyloid Polypeptide Permeabilizes Synthetic Vesicles by a Pore-like Mechanism that May Be Relevant to Type II DiabetesBiochemistry, 2002
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils 1 1Edited by M. MoodyJournal of Molecular Biology, 2002
- Designing conditions for in vitro formation of amyloid protofilaments and fibrilsProceedings of the National Academy of Sciences, 1999
- Propagating structure of Alzheimer’s β-amyloid (10–35) is parallel β-sheet with residues in exact registerProceedings of the National Academy of Sciences, 1998
- Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.Journal of Biological Chemistry, 1992